Tirzepatide dosage chart in mg and units

The FDA-approved labels for Zepbound and Mounjaro start tirzepatide at 2.5 mg once a week and allow increases in 2.5 mg steps, at least 4 weeks apart, up to 15 mg in adults.1, 2 This page lays that schedule out as a chart and shows how milligrams convert to syringe units. It reports the label. It does not tell you what to take.

Tirzepatide dosage chart from the FDA label

Label schedule for Zepbound and Mounjaro, once weekly. Your prescriber decides whether and when to move between doses.
DoseWhat the labels say about it
2.5 mgStarting dosage. Zepbound: for 4 weeks, for starting only, not an approved maintenance dosage1
5 mgNext step after 4 weeks on 2.5 mg. A Zepbound maintenance dosage for weight reduction1
7.5 mgA step between doses, after at least 4 weeks on 5 mg1, 2
10 mgA Zepbound maintenance dosage for weight reduction and for sleep apnea.1 Maximum for pediatric Mounjaro patients (aged 10 and older)2
12.5 mgA step between doses, after at least 4 weeks on 10 mg1, 2
15 mgMaximum dosage for adults on both labels. A Zepbound maintenance dosage1, 2

Two rules sit behind every row: each increase is 2.5 mg, and it comes after at least 4 weeks on the current dose.1, 2

Zepbound and Mounjaro: what differs

ItemZepboundMounjaro
Approved forWeight reduction in adults with obesity, or overweight with a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesity1Blood sugar control in type 2 diabetes from age 10; lowering the risk of major cardiovascular events in adults with type 2 diabetes at high risk2
Starting dosage2.5 mg weekly for 4 weeks12.5 mg weekly2
IncreasesTo 5 mg after 4 weeks, then 2.5 mg steps after at least 4 weeks each12.5 mg steps after at least 4 weeks, if more blood sugar control is needed2
Maintenance5, 10 or 15 mg for weight; 10 or 15 mg for sleep apnea1Set by blood sugar needs2
Maximum15 mg weekly115 mg weekly in adults; 10 mg weekly in pediatric patients aged 10 and older2

The Zepbound label tells prescribers to consider response and tolerability when choosing a maintenance dosage, and to consider a lower one if a dose is not tolerated.1 It also does not recommend using Zepbound together with other tirzepatide products or any GLP-1 receptor agonist.1

Milligrams, millilitres and units

The labels give every dose in milligrams. A syringe measures liquid, and on a U-100 insulin syringe 1 mL equals 100 units.4 How many units hold a given number of milligrams depends on how concentrated the liquid is. See units are not milligrams.

Lilly pens and vials

Single-dose pens and single-dose vials hold one dose in 0.5 mL. Multi-dose vials and KwikPens hold 4 doses in 2.4 mL, so each dose is 0.6 mL.1, 2 For vials, the labels say to use a syringe that suits the dose, such as a 1 mL syringe that can measure 0.5 mL or 0.6 mL, and a new syringe and needle for every injection.1, 2 The Zepbound vial instructions have the patient draw to the 0.5 mL line for a single-dose vial and to the 0.6 mL line for a multi-dose vial.1

Volumes are from the labels. Units are arithmetic (mL × 100) for a U-100 syringe.
DoseSingle-dose vialUnitsMulti-dose vialPer doseUnits
2.5 mg0.5 mL5010 mg / 2.4 mL0.6 mL60
5 mg0.5 mL5020 mg / 2.4 mL0.6 mL60
7.5 mg0.5 mL5030 mg / 2.4 mL0.6 mL60
10 mg0.5 mL5040 mg / 2.4 mL0.6 mL60
12.5 mg0.5 mL5050 mg / 2.4 mL0.6 mL60
15 mg0.5 mL5060 mg / 2.4 mL0.6 mL60

This table applies to vials drawn up with a syringe, not to pens.

Compounded tirzepatide

A compounded vial can have a different concentration from Lilly's products, so the unit numbers above do not carry over. The concentration is printed on your pharmacy label in mg/mL. The FDA says compounded drugs are not FDA-approved, and that it has received reports of compounded tirzepatide being prescribed at doses beyond the approved label, including faster increases.3

Arithmetic examples only. Units on a U-100 syringe at three example concentrations. Use your own label's concentration.
Amount5 mg/mL10 mg/mL20 mg/mL
2.5 mg502512.5
5 mg1005025
7.5 mg150 (more than one 1 mL syringe)7537.5
10 mg200 (more than one 1 mL syringe)10050
12.5 mg250 (more than one 1 mL syringe)125 (more than one 1 mL syringe)62.5
15 mg300 (more than one 1 mL syringe)150 (more than one 1 mL syringe)75

The FDA has also received reports of adverse events, some needing hospital care, that may be linked to dosing errors with compounded injectable semaglutide.3 If your label and your instructions do not seem to match, ask the pharmacy before drawing a dose.

Work out units for your vial

Enter the concentration from your label and the dose your prescriber wrote. The calculator never fills in a dose.

Tirzepatide units calculator

mg/mL
Dose unit choose one
Syringe size units it holds

For a fuller conversion table, see the tirzepatide mg to units chart. Looking for one brand only? See the Zepbound dosage chart or the Mounjaro dosage chart. Comparing brands or drugs? See Mounjaro vs Zepbound and tirzepatide vs semaglutide. If your vial is a powder that you mix yourself, use the tirzepatide reconstitution calculator. To check an amount you have already drawn, use units to mg.

Missed doses and changing your day

  • Take a missed dose as soon as possible within 4 days (96 hours).1, 2
  • If more than 4 days have passed, skip it and take the next dose on the regular day.1, 2
  • The weekly day can be changed as long as two doses are at least 3 days (72 hours) apart.1, 2

How the labels say to inject

  • Once a week, at any time of day, with or without meals.1, 2
  • Under the skin of the abdomen or thigh. The back of the upper arm is for when another person gives the injection.1, 2
  • Rotate the site with each dose.1, 2
  • The liquid should be clear and colorless to slightly yellow. Do not use it if you see particles or discoloration.1, 2
  • Never share a KwikPen with another person, even with a new needle.1, 2

Side effects and warnings on the label

The most common side effects listed for Zepbound are nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, fatigue, allergic reactions, belching, hair loss and reflux.1

The Mounjaro label lists nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain.2

Both labels carry a boxed warning about thyroid C-cell tumors, which tirzepatide causes in rats; whether it does so in humans is unknown.1, 2 Tirzepatide is contraindicated for people with a personal or family history of medullary thyroid carcinoma or with MEN 2, and for people with a known serious allergy to it.1, 2 This is not the full safety information. Read the Medication Guide that comes with your prescription.

Storage, from the labels

The Zepbound and Mounjaro labels give the same storage rules.1, 2

  • Keep in the refrigerator at 2°C to 8°C (36°F to 46°F), in the original carton, away from heat and light.
  • Do not freeze, and do not use it if it has been frozen.
  • Single-dose pens and vials can be kept out of the fridge, at up to 30°C (86°F), for a total of 21 days. After that they are discarded.
  • An unopened multi-dose vial or KwikPen kept at room temperature is discarded after 30 days.
  • An opened multi-dose vial or KwikPen is discarded 30 days after first use, or after 4 weekly doses, even if medicine remains.

Compounded products have their own storage instructions and beyond-use date. Follow your pharmacy label.

Questions

What is the starting dose of tirzepatide?

The Zepbound and Mounjaro labels both give a starting dosage of 2.5 mg injected under the skin once a week. Your prescriber decides your dose.

What is the maximum dose of tirzepatide?

The labels give a maximum of 15 mg once a week for adults. The Mounjaro label gives a maximum of 10 mg once a week for pediatric patients aged 10 and older.

How many units is 2.5 mg of tirzepatide?

It depends on the concentration of your product. In a Lilly single-dose vial, 2.5 mg is 0.5 mL, which is 50 units on a U-100 syringe. For other concentrations the arithmetic gives 50 units at 5 mg/mL, 25 units at 10 mg/mL, 12.5 units at 20 mg/mL. Check your own label.

How long do you stay on each dose?

The labels say at least 4 weeks on the current dose before any increase. They do not say everyone must increase.

Is the Mounjaro dosage chart the same as Zepbound?

Both labels start at 2.5 mg weekly and increase in 2.5 mg steps after at least 4 weeks, up to 15 mg in adults. They differ in what the drug is approved for and in how the target dose is chosen.

Can you stay on 2.5 mg of Zepbound?

The Zepbound label says 2.5 mg is for starting treatment and is not an approved maintenance dosage. Talk to your prescriber about what suits you.

What if I miss a dose of tirzepatide?

The labels say to take it as soon as possible within 4 days (96 hours). If more than 4 days have passed, skip it and take the next dose on your regular day.

Are compounded tirzepatide doses the same as the label?

Not necessarily. The FDA says compounded drugs are not FDA-approved, and it has received reports of compounded tirzepatide prescribed at doses beyond the approved label. Follow your prescription and ask your pharmacy.

How long can tirzepatide stay out of the fridge?

The Zepbound and Mounjaro labels allow single-dose pens and vials to be kept at up to 30°C (86°F) for a total of 21 days. Compounded products follow the pharmacy label instead.

Is Zepbound approved for children?

No. The Zepbound label says safety and effectiveness have not been established in pediatric patients. Mounjaro is approved for type 2 diabetes from age 10.

Does this page tell me what dose to take?

No. It reports what the FDA-approved labels say and shows arithmetic. Your prescriber sets your dose.

Sources

  1. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information and Instructions for Use, revised 8/2026. uspl.lilly.com/zepbound (opens in a new tab)
  2. Eli Lilly and Company. Mounjaro (tirzepatide) prescribing information, revised 8/2026. uspl.lilly.com/mounjaro (opens in a new tab)
  3. U.S. Food and Drug Administration, "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss", content current as of 1 October 2026. fda.gov (opens in a new tab)
  4. Pennsylvania Patient Safety Authority, newsletter, June 2025: insulin syringes are marked in units, with 1 mL equal to 100 units. patientsafety.pa.gov (opens in a new tab)
  5. Formulas and test cases: how the calculator math works.